Atlanta 1/20/2013 5:24:13 AM
SciClone Pharmaceuticals Inc. (Stock Symbol: NASDAQ: SCLN) is now on LinkMyStock.com
SciClone Pharmaceuticals Inc. has joined LinkMyStock.com. Now Stock Brokers, Brokerage Firms and Investors/Shareholders from around the world who follow SciClone Pharmaceuticals Inc. can link directly to SciClone Pharmaceuticals Inc. Link My Stock Hub. Brokers and Brokerage Firms that link to SciClone Pharmaceuticals Inc. typically are familiar with the company and can facilitate transactions in SciClone Pharmaceuticals Inc. security. Investors linking to SciClone Pharmaceuticals Inc. usually are either existing shareholders looking to stay informed when SciClone Pharmaceuticals Inc. posts new information or people that are simply interested in SciClone Pharmaceuticals Inc. that are not yet or may never become shareholders.
LinkMyStock is a premier financial networking platform designed specifically for public companies, brokerage firms, brokers and investors. LinkMyStock.com provides a network that consists of brokers, brokerage firms and investors that can link directly to the companies that they follow. With brokers from around the world having the ability to select companies to link to that are members of Link My Stock this provides investors with the ability to locate brokers and contact them to find out more information about a company they are interested in learning more about.
LinkMyStock.com provides every member with their own hub where they post content. Content sections include; press releases, blogs, pictures, videos, Right Now status updates, events, jobs and more in order to attract more visitors and increase the number of search results along with improving indexing.
To link to the SciClone Pharmaceuticals Inc.'s Link My Stock Hub sign into your Link My Stock Hub or Join Link My Stock today.
About SciClone Pharmaceuticals Inc.
SciClone is a US-based, China-focused specialty pharmaceutical company with a substantial revenue-generating and profitable commercial business and a broad marketed product portfolio of differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders
